Related Experiment Video
Updated: Jul 2, 2025

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
The MAPP Room Memory Test: Examining Contextual Memory Using a Novel Computerized Test in Cognitively-Unimpaired
A Giudicessi1, P A Aduen, J T Fox-Fuller
1Yakeel T. Quiroz, PhD, Associate Professor, Harvard Medical School, Departments of Psychiatry and Neurology, Massachusetts General Hospital 39 1st Avenue, Suite 101, Charlestown, MA 02129, Phone: 617-643-5883.
Cognitively-unimpaired Alzheimer's disease (AD) mutation carriers showed impaired contextual memory on a new test. The MAPP Room Memory Test may detect early AD-related cognitive changes.
Area of Science:
- Neuroscience
- Cognitive Psychology
- Genetics
Background:
- Contextual memory, crucial for recalling event details, is impaired in Alzheimer's disease (AD).
- Existing tests for contextual memory are insufficient, particularly for visuospatial aspects.
- Autosomal dominant AD mutations, like Presenilin-1 E280A, offer insights into early AD pathology.
Purpose of the Study:
- To develop and evaluate a novel computerized test, the MAPP Room Memory Test, for assessing visuospatial contextual memory.
- To investigate whether cognitively-unimpaired carriers of the Presenilin-1 E280A mutation exhibit deficits in contextual memory compared to non-carriers.
Main Methods:
- Development of the MAPP Room Memory Test, a computerized cognitive assessment.
- Participants identified previously presented target items within visual scenes.
- Comparison of performance between mutation carriers (n=15) and non-carriers (n=31) from autosomal dominant AD families.
Main Results:
- Mutation carriers demonstrated significantly poorer delayed room recognition compared to non-carriers.
- The MAPP Room Memory Test revealed subtle cognitive differences in at-risk individuals.
- Results suggest the test's sensitivity to early cognitive changes associated with AD risk.
Conclusions:
- The MAPP Room Memory Test shows promise in detecting early, subtle cognitive impairments related to Alzheimer's disease risk.
- Further research with larger cohorts and biomarkers is warranted to validate the test's utility in preclinical AD.
- This test could aid in identifying individuals at higher risk for AD, facilitating early intervention strategies.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Role of Hippocampus in Memory

